Synthesis of Therapeutic Agents The gene coding for VP1 is cloned in pMB 9 pUC 19 pUC 18 pBR 322 pMB 9 pUC 19 pUC 18 pBR 322 ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents Recombinant vaccine for HBV was produced by cloning viral genes in plasmids phagemids autonomously replicating plasmid of yeast cosmids plasmids phagemids autonomously replicating plasmid of yeast cosmids ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents Recombinant vaccine for Hepatitis B virus has been synthesized against which of the following antigen? e antigen (HBeAg) All of these Viral surface antigen (HBsAg) Viral core antigen (HBcAg) e antigen (HBeAg) All of these Viral surface antigen (HBsAg) Viral core antigen (HBcAg) ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents The promoter used for cloning HBV surface antigen is β-galactosidase alcohol dehydrogenase 1 polyhedrin galactokinase β-galactosidase alcohol dehydrogenase 1 polyhedrin galactokinase ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents Chemically synthesized DNA sequences for the two chains are separately inserted into the plasmid pBR 322 by the side of β-Galactosidase acid phosphatase galactokinase glucokinase β-Galactosidase acid phosphatase galactokinase glucokinase ANSWER DOWNLOAD EXAMIANS APP
Synthesis of Therapeutic Agents The two chains of insulin can be separated by detaching it from β-galactosidase using hydrogen chloride cyanogen bromide peptidase protease hydrogen chloride cyanogen bromide peptidase protease ANSWER DOWNLOAD EXAMIANS APP